Plasma ghrelin following cure of Helicobacter pylori

Gut

Volumn 52, Issue 5, 2003, Pages 637-640

  Nwokolo, C U ^a   Freshwater, D A ^a   O'Hare, P ^a   Randeva, H S ^b  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; GHRELIN; LEPTIN;

ADENOCARCINOMA; ADULT; APPETITE; ARTICLE; BACTERIAL COUNT; BODY COMPOSITION; BODY MASS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERADICATION THERAPY; ESOPHAGUS CANCER; FEMALE; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HORMONE BLOOD LEVEL; HUMAN; MALE; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; STOMACH PH; TIME SERIES ANALYSIS; WEIGHT GAIN; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; ESOPHAGEAL NEOPLASMS; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTRINS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LEPTIN; MALE; PEPTIDE HORMONES; RADIOIMMUNOASSAY;

EID: 0038639060     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.5.637     Document Type: Article

References (42)

1. Chow W, Blaser M, Blot W, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90.
2. Boulton-Jones J, Logan R. An inverse relation between cagA-positive strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Helicobacter 1999;4:281-3.
3. Grimley C, Holder R, Loft D, et al. Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol 1999;11:503-9.
4. Malfertheiner P, Deltenre M, Sipponen P. Helicobacter pylori, the cardia, and gastroesophageal reflux disease. Curr Opin Gastroenterol 1999;15: S57-60.
5. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-90.
6. Cameron A. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487-94.
7. Spechler S. Disputing dysplasia. Gastroenterology. 2001;120:1607-19
8. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesaphageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
9. Kojima M, Hosoda H, Dale Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60.
10. Inui I. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nature Reviews Neuroscience 2001;2:551-60
11. Tomasetto C, Karam SM, Ribieras S, et al. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 2000;119:395-405.
12. Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite-stimulatory signal from the stomach with structural resemblance to motilin. Gastroentrology 2001;120:337-45.
13. Wren A, Seal L, Cohen M, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992.
14. Wren A, Small C, Abbott C, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540-7.
15. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-13.
16. Nakazato M, Mukakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-8.
17. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-8.
18. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346:1623-30.
19. Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000;85:4908-11.
20. Kojima M, Hosoda H, Matsuo H, et al. Ghrelin: discovery of the natural endoqenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001;12:118-22.
21. Cummings DE, Purnell JQ, Scott Frayo R, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714-19.
22. Tschop M, Wawarta R, Riepl R, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001;24:RC19-21.
23. Schneider R, Bornstein SR, Chrousos GP, et al. Leptin mediates a proliferative response in human gastric mucosa cell with functional receptor. Horm Metab Res 2001;33:1-6.
24. Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature 1998;394:790-3.
25. Azuma T, Suto H, Ito Y, et al. Gastric leptin and helicobacter pylori infection. Gut 2001;49:324-9.
26. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992-5.
27. Furuta T, Shirai N, Xiao F, et al. Effect of Helicobacter infection and its eradication on nutrition. Aliment Pharmacol Ther 2002;4:799-806.
28. Richter T, Richter T, List S, et al. Five- to 7-year-old children with Helicobacter pylori infection are smaller than Helicobacter-negative children: a cross-sectional population- based study of 3,315 children. J Pediatr Gastroenterol Nutr 2001;33:472-5.
29. Buyukgebiz A, Dundar B, Bober E, et al. Helicobacter pylori infection in children with constitutional delay of growth and puberty. J Pediatr Endocrinol 2001;14:549-51.
30. Demir H, Saltik I, Kocak N, et al. Subnormal growth in children with Helicobacter pylori infection. Arch Dis Child 2001;84:89-90.
31. Jolobe O. Helicobacter pylori infection with iron deficiency anaemia and subnormal growth at puberty. Arch Dis Child 2000;82:136-40.
32. Sauve-Martin H, Kalach N, Raymond J, et al. The rate of Helicobacter pylori infection in children with growth retardation. J Pediatr Gastroenterol Nutr 1999;28:354-5.
33. Aggarwal A. Helicobacter pylori infection: a cause of growth delay in children. Indian Pediatr 1998;35:191-2.
34. Iijima K, Henry E, Moriya A, et al. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology 2002;122: 1248-57.
35. Peterson W. Gastrin and acid in relation to Helicobacter pylori. Aliment Pharmacol Ther 1996;10(suppl 1):97-102.
36. Witteman E, Verhulst M, de KoR, et al. Basal serum gastrin concentrations before and after eradication of Helicobacter pylori infection measured by sequence specific radioimmunoassays. Aliment Pharmacol Ther 1994;8:515-19.
37. Smith J, Pounder R, Nwokolo C, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990;31:522-5.
38. Prewett E, Smith J, Nwokolo C, et al. Eradication of Helicobacter pylori abolishes 24- hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther 1991;5:283-90.
39. Arosio M, Ronchi CL, Gebbia C, et al. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrine Metab 2003;88:701-4.
40. MasudaY, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000;276:905-8.
41. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002;123:1120-8.
42. Randeva HS, Murray RD, Lewandowski KC, et al. Differential effects of GH replacement on the components of the leptin system in GH-deficient individuals. J Clin Endocrinol Metab 2002;87:798-804.